Candida albicans biofilms do not trigger reactive oxygen species and evade neutrophil killing

Journal of Infectious Diseases

Volumn 206, Issue 12, 2012, Pages 1936-1945

  Xie, Zhihong ^a   Thompson, Angela ^a   Sobue, Takanori ^a   Kashleva, Helena ^a   Xu, Hongbin ^a   Vasilakos, John ^b   Dongari Bagtzoglou, Anna ^a  

^a UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

^b Department of Biothera ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GLUCAN; DICHLORODIHYDROFLUORESCEIN DIACETATE; REACTIVE OXYGEN METABOLITE;

ANTIMICROBIAL ACTIVITY; ARTICLE; BIOFILM; CANDIDA ALBICANS; CATHETER; EXTRACELLULAR MATRIX; IMMUNOCOMPETENT CELL; IN VIVO STUDY; INNATE IMMUNITY; LEUKOCYTE; LEUKOCYTE ACTIVATION; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL;

BIOFILMS; CANDIDA ALBICANS; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNE EVASION; MICROBIAL VIABILITY; NEUTROPHILS; REACTIVE OXYGEN SPECIES;

EID: 84870158218     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jis607     Document Type: Article

References (50)

1. Jesaitis AJ, Franklin MJ, Berglund D, et al. Compromised host defense on Pseudomonas aeruginosa biofilms: Characterization of neutrophil and biofilm interactions. J Immunol 2003; 171:4329-39. (Pubitemid 37243006)
2. Scaramuzzino D, McNiff JM, Bessen DE. Humanized in vivo model for streptococcal impetigo. Infect Immun 2000; 68:2880-7. (Pubitemid 30253868)
3. Dongari-Bagtzoglou A, Kashleva H, Dwivedi P, Diaz P, Vasilakos J. Characterization of mucosal Candida albicans biofilms. PLoS One 2009; 4:e7967.
4. Günther F, Wabnitz GH, Stroh P, et al. Host defence against Staphylococcus aureus biofilms infection: Phagocytosis of biofilms by polymorphonuclear neutrophils (PMN). Mol Immunol 2009; 46:1805-13.
5. Leid J, Shirtliff ME, Costerton JW, Stoodley P. Human leukocytes adhere to, penetrate, and respond to Staphylococcus aureus biofilms. Infect Immun 2002; 70:6339-45. (Pubitemid 35192726)
6. Cerca N, Jefferson KK, Oliveira R, Pier GB, Azeredo J. Comparative antibody-mediated phagocytosis of Staphylococcus epidermidis cells grown in a biofilm or in the planktonic state. Infect Immun 2006; 74:4849-55. (Pubitemid 44157272)
7. Kristian S, Birkenstock TA, Sauder U, Mack D, Götz F, Landmann R. Biofilm formation induces C3a release and protects Staphylococcus epidermidis from IgG and complement deposition and from neutrophildependent killing. J Infect Dis 2008; 197:1028-35. (Pubitemid 351590032)
8. Meluleni G, Grout M, Evans DJ, Pier GB. Mucoid Pseudomonas aeruginosa growing in a biofilm in vitro are killed by opsonic antibodies to the mucoid exopolysaccharide capsule but not by antibodies produced during chronic lung infection in cystic fibrosis patients. J Immunol 1995; 155:2029-38.
9. Chandra J, McCormick TS, Imamura Y, Mukherjee PK, Ghannoum MA. Interaction of Candida albicans with adherent human peripheral blood mononuclear cells increases C. albicans biofilm formation and results in differential expression of pro- and anti-inflammatory cytokines. Infect Immun 2007; 75:2612-20. (Pubitemid 46744353)
10. Katragkou A, Kruhlak MJ, Simitsopoulou M, et al. Interactions between human phagocytes and Candida albicans biofilms alone and in combination with antifungal agents. J Infect Dis 2010; 201:1941-9.
11. Katragkou A, Chatzimoschou A, Simitsopoulou M, Georgiadou E, Roilides E. Additive antifungal activity of anidulafungin and human neutrophils against Candida parapsilosis biofilms. J Antimicrob Chemother 2011; 66:588-91.
12. Katragkou A, Simitsopoulou M, Chatzimoschou A, Georgiadou E, Walsh TJ, Roilides E. Effects of interferon-γ and granulocyte colonystimulating factor on antifungal activity of human polymorphonuclear neutrophils against Candida albicans grown as biofilms or planktonic cells. Cytokine 2011; 55:330-4.
13. Gillum A, Tsay EY, Kirsch DR. Isolation of the Candida albicans gene for orotidine-5'-phosphate decarboxylase by complementation of Scerevisiae Ura3 and Escherichia coli Pyrf mutations. Mol Gen Genet 1984; 198:179-82. (Pubitemid 15180998)
14. Harriott M, Noverr MC. Candida albicans and Staphylococcus aureus form polymicrobial biofilms: Effects on antimicrobial resistance. Antimicrob Agents Chemother 2009; 53:3914-22.
15. Nett J, Sanchez H, Cain MT, Andes DR. Genetic basis of Candida biofilm resistance due to drug-sequestering matrix glucan. Infect Dis 2010; 202:171-5.
16. Dwivedi P, Thompson A, Xie Z, et al. Role of Bcr1-activated genes Hwp1 and Hyr1 in Candida albicans oral mucosal biofilms and neutrophil evasion. PLoS One 2011; 6:e16218.
17. Mullick A, Elias M, Harakidas P, et al. Gene expression in HL60 granulocytoids and human polymorphonuclear leukocytes exposed to Candida albicans. Infect Immun 2004; 72:414-29. (Pubitemid 38018203)
18. Rescigno M, Rotta G, Valzasina B, Ricciardi-Castagnoli P. Dendritic cells shuttle microbes across gut epithelial monolayers. Immunobiology 2001; 204:572-81. (Pubitemid 34134169)
19. Xie Z, Thompson A, Kashleva H, Dongari-Bagtzoglou A. A quantitative real-time RT-PCR assay for mature C. albicans biofilms. BMC Microbiol 2011; 11:e93.
20. Schooling S, Beveridge TJ. Membrane vesicles: An overlooked component of the matrices of biofilms. J Bacteriol 2006; 188:5945-57. (Pubitemid 44384103)
21. Martins M, Uppuluri P, Thomas DP, et al. Presence of extracellular DNA in the Candida albicans biofilm matrix and its contribution to biofilms. Mycopathologia 2010; 169:323-31.
22. Cateau E, Berjeaud JM, Imbert C. Possible role of azole and echinocandin lock solutions in the control of Candida biofilms associated with silicone. Int J Antimicrob Agents 2011; 37:380-4.
23. Chandra J, Mukherjee PK, Leidich SD, et al. Antifungal resistance of candidal biofilms formed on denture acrylic in vitro. J Dent Res 2001; 80:903-8. (Pubitemid 32477425)
24. Kaneko Y, Ohno H, Fukazawa H, et al. Anti-Candida biofilm activity of micafungin is attenuated by voriconazole but restored by pharmacological inhibition of Hsp90-related stress responses. Med Mycol 2010; 48:606-12.
25. Ku T, Palanisamy SK, Lee SA. Susceptibility of Candida albicans biofilms to azithromycin, tigecycline and vancomycin and the interaction between tigecycline and antifungals. Int J Antimicrob Agents 2010; 36:441-6.
26. Nett J, Sanchez H, Cain MT, Ross KM, Andes DR. Interface of Candida albicans biofilm matrix-associated drug resistance and cell wall integrity regulation. Eukaryot Cell 2011; 10:1660-9.
27. Aratani Y, Kura F, Watanabe H, et al. Relative contributions of myeloperoxidase and NADPH-oxidase to the early host defense against pulmonary infections with Candida albicans and Aspergillus fumigatus. Med Mycol 2002; 40:557-63. (Pubitemid 36050146)
28. Linden J, Maccani MA, Laforce-Nesbitt SS, Bliss JM. High efficiency opsonin-independent phagocytosis of Candida parapsilosis by human neutrophils. Med Mycol 2010; 48:355-64.
29. Wagner C, Zimmermann S, Brenner-Weiss G, et al. The quorumsensing molecule N-3-oxododecanoyl homoserine lactone (3OC12- HSL) enhances the host defence by activating human polymorphonuclear neutrophils (PMN). Anal Bioanal Chem 2007; 387:481-7. (Pubitemid 46067463)
30. Zimmermann S, Wagner C, Müller W, et al. Induction of neutrophil chemotaxis by the quorum-sensing molecule N-(3-oxododecanoyl)-Lhomoserine lactone. Infect Immun 2006; 74:5687-92. (Pubitemid 44484552)
31. Al-Fattani M, Douglas LJ. Biofilm matrix of Candida albicans and Candida tropicalis: Chemical composition and role in drug resistance. J Med Microbiol 2006; 55(Pt 8):999-1008. (Pubitemid 44215557)
32. Baillie G, Douglas LJ. Matrix polymers of Candida biofilms and their possible role in biofilm resistance to antifungal agents. J Antimicrob Chemother 2000; 46:397-403.
33. Cassone A, Mattia E, Boldrini L. Agglutination of blastospores of Candida albicans by concanavalin A and its relationship with the distribution of mannan polymers and the ultrastructure of the cell wall. J Gen Microbiol 1978; 105:263-73. (Pubitemid 8307724)
34. Pistole T. Interaction of bacteria and fungi with lectins and lectin-like substances. Annu Rev Microbiol 1981; 35:85-112.
35. García-Sánchez S, Aubert S, Iraqui I, Janbon G, Ghigo JM, d'Enfert C. Candida albicans biofilms: A developmental state associated with specific and stable gene expression patterns. Eukaryot Cell 2004; 3:536-45. (Pubitemid 38497991)
36. Yeater K, Chandra J, Cheng G, et al. Temporal analysis of Candida albicans gene expression during biofilm development. Microbiology 2007; 153:2373-85. (Pubitemid 47262027)
37. Balish E, Warner TF, Nicholas PJ, Paulling EE, Westwater C, Schofield DA. Susceptibility of germfree phagocyte oxidase- and nitric oxide synthase 2-deficient mice, defective in the production of reactive metabolites of both oxygen and nitrogen, to mucosal and systemic candidiasis of endogenous origin. Infect Immun 2005; 73:1313-20. (Pubitemid 40470716)
38. Fradin C, Mavor AL, Weindl G, et al. The early transcriptional response of human granulocytes to infection with Candida albicans is not essential for killing but reflects cellular communications. Infect Immun 2007; 75:1493-501. (Pubitemid 46385843)
39. Bambach A, Fernandes MP, Ghosh A, et al. Goa1p of Candida albicans localizes to the mitochondria during stress and is required for mitochondrial function and virulence. Eukaryot Cell 2009; 8:1706-20.
40. Enjalbert B, MacCallum DM, Odds FC, Brown AJ. Niche-specific activation of the oxidative stress response by the pathogenic fungus Candida albicans. Infect Immun 2007; 75:2143-51. (Pubitemid 46744300)
41. Tateda K, Ishii Y, Yamaguchi K, Horikawa M, Ishikuro M. Suppressive effects of macrolides and their derivatives on quorum sensing systems in Pseudomonas aeruginosa. Jpn J Antibiot 2003; 56:80-6. (Pubitemid 36362272)
42. Alem M, Douglas LJ. Prostaglandin production during growth of Candida albicans biofilms. J Med Microbiol 2005; 54:1001-5. (Pubitemid 41566768)
43. Naruo S, Okajima K, Taoka Y, et al. Prostaglandin E1 reduces compression trauma-induced spinal cord injury in rats mainly by inhibiting neutrophil activation. J Neurotrauma 2003; 20:221-8. (Pubitemid 36292830)
44. Smail E, Kolotila MP, Ruggeri R, Diamond RD. Natural inhibitor from Candida albicans blocks release of azurophil and specific granule contents by chemotactic peptide-stimulated human neutrophils. Infect Immun 1989; 57:689-92. (Pubitemid 19064528)
45. Sonck E, Stuyven E, Goddeeris B, Cox E. The effect of beta-glucans on porcine leukocytes. Vet Immunol Immunopathol 2010; 135: 199-207.
46. van Bruggen R, Drewniak A, Jansen M, et al. Complement receptor 3, not dectin-1, is the major receptor on human neutrophils for betaglucan- bearing particles. Mol Immunol 2009; 47:575-81.
47. Wakshull E, Brunke-Reese D, Lindermuth J, et al. PGG-glucan, a soluble beta-(1,3)-glucan, enhances the oxidative burst response, microbicidal activity, and activates an NF-kappa B-like factor in human PMN: Evidence for a glycosphingolipid beta-(1,3)-glucan receptor. Immunopharmacology 1999; 41:89-107. (Pubitemid 29099822)
48. Kennedy A, Willment JA, Dorward DW, Williams DL, Brown GD, DeLeo FR. Dectin-1 promotes fungicidal activity of human neutrophils. Eur J Immunol 2007; 37:467-78. (Pubitemid 46915586)
49. Brown G, Taylor PR, Reid DM, et al. Dectin-1 is a major beta-glucan receptor on macrophages. J Exp Med 2002; 196:407-12. (Pubitemid 34875669)
50. Goodridge H, Reyes CN, Becker CA, et al. Activation of the innate immune receptor dectin-1 upon formation of a "phagocytic synapse." Nature 2011; 472:471-5.